Ventripoint Diagnostics Ltd

RunWithRugs · 2026-03-06T03:24:46+00:00

Ventripoint Diagnostics Ltd has received approval from the TSX Venture Exchange for the issuance of 291,344 common shares, totaling $36,989.01 in interest on outstanding Convertible Debentures. The company's shares are trading at $0.11.

RunWithRugs

2026-03-06 03:24:46

Abstract generation in progress

(MENAFN- Baystreet) 01:26 PM EST - Ventripoint Diagnostics Ltd: Announces it has received approval from the TSX Venture Exchange and issued of 291,344 common shares for the payment of an aggregate of $36,989.01 of interest owing on certain outstanding Convertible Debentures issued by the Corporation on June 28, 2024, December 16, 2024, January 17, 2025, and February 7, 2025. Ventripoint Diagnostics Ltd shares V are trading ** up one cent** at $0.11.

Full Press Release:

MENAFN04032026000212011056ID1110819142

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.